02/27/2025
4:00 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
3:41 PM | BML Investment Partners, L.P. (Filed by)
Oramed Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
3:30 PM | Gabay Avraham (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
3:31 PM | KIDRON NADAV (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
3:31 PM | Hexter Joshua (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
3:31 PM | Kidron Miriam (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
3:35 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2025
8:18 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
7:31 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
4:01 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
1:12 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ORMP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
09/23/2024
7:06 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
3:42 PM | BML Investment Partners, L.P. (Filed by)
Oramed Pharmaceuticals (Subject)
| Form SC 13G | |
06/26/2024
8:00 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2024
8:00 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
3:15 PM | Gabay Avraham (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
6:32 AM | Oramed Pharmaceuticals (Filer)
| Form ARS | |
06/20/2024
6:30 AM | Oramed Pharmaceuticals (Filer)
| Form DEF 14A | |
06/10/2024
4:28 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
4:15 PM | Oramed Pharmaceuticals (Issuer)
Reznick Yehuda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:00 PM | Oramed Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
8:00 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
7:07 PM | Oramed Pharmaceuticals (Issuer)
Reznick Yehuda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
4:30 PM | Oramed Pharmaceuticals (Issuer)
Reznick Yehuda (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/22/2024
8:30 PM | KIDRON NADAV (Filed by)
Oramed Pharmaceuticals (Subject)
| Form SC 13D | |
03/19/2024
7:00 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
4:15 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
